Literature DB >> 10417143

Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

M A Curtis1, A Thickett, J M Slaney, M Rangarajan, J Aduse-Opoku, P Shepherd, N Paramonov, E F Hounsell.   

Abstract

Proteases of Porphyromonas gingivalis are considered to be important virulence determinants of this periodontal bacterium. Several biochemical isoforms of arginine-specific proteases are derived from rgpA and rgpB. HRgpA is a heterodimer composed of the catalytic alpha chain noncovalently associated with a beta adhesin chain derived from the C terminus of the initial full-length translation product. The catalytic alpha chain is also present as a monomer (RgpA) either free in solution or associated with membranes. rgpB lacks the coding region for the adhesin domain present in rgpA and yields only monomeric forms (RgpB) which again may be soluble or membrane associated. In this study, the catalytic chains of this unusual group of enzymes are shown to be differentially modified by the posttranslational addition of carbohydrate. A monoclonal antibody (MAb 1B5) raised to the monomeric RgpA did not react with the corresponding recombinant RgpA alpha chain expressed in Escherichia coli but was immunoreactive with P. gingivalis lipopolysaccharide. MAb 1B5 also reacted with the membrane-associated forms of RgpA and RgpB but not with the heterodimeric HRgpA and the soluble form of RgpB. RgpA treated with denaturants was capable of binding to MAb 1B5 whereas treatment with periodate abolished this binding, suggesting the presence of carbohydrate residues within the epitope. Chemical deglycosylation abolished immunoreactivity with MAb 1B5 and caused a approximately 30% reduction in the size of the membrane-associated enzymes. Monosaccharide analysis of HRgpA and RgpA demonstrated 2.1 and 14.4%, respectively, carbohydrate by weight of protein. Furthermore, distinct differences were detected in their monosaccharide compositions, indicating that these protease isoforms are modified not only to different extents but also with different sugars. The variable nature of these additions may have a significant effect on the structure, stability, and immune recognition of these protease glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417143      PMCID: PMC96659     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Structural (shape-maintaining) role of the cell surface glycoprotein of Halobacterium salinarium.

Authors:  M F Mescher; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Characterization of the glycosylation status of proteins.

Authors:  E F Hounsell
Journal:  Mol Biotechnol       Date:  1994-08       Impact factor: 2.695

5.  A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.

Authors:  C A Genco; B M Odusanya; J Potempa; J Mikolajczyk-Pawlinska; J Travis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis.

Authors:  J Potempa; J Mikolajczyk-Pawlinska; D Brassell; D Nelson; I B Thøgersen; J J Enghild; J Travis
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

7.  The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis.

Authors:  C G Kelly; V Booth; H Kendal; J M Slaney; M A Curtis; T Lehner
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

8.  Altered expression and modification of proteases from an avirulent mutant of Porphyromonas gingivalis W50 (W50/BE1).

Authors:  Lucy M Collinson; Minnie Rangarajan; Michael A Curtis
Journal:  Microbiology (Reading)       Date:  1998-09       Impact factor: 2.777

9.  Detailed structural analysis of a novel, specific O-linked glycan from the prokaryote Flavobacterium meningosepticum.

Authors:  B B Reinhold; C R Hauer; T H Plummer; V N Reinhold
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins.

Authors:  H A Schenkein; H M Fletcher; M Bodnar; F L Macrina
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

View more
  64 in total

1.  Selective sorting of cargo proteins into bacterial membrane vesicles.

Authors:  M Florencia Haurat; Joseph Aduse-Opoku; Minnie Rangarajan; Loredana Dorobantu; Murray R Gray; Michael A Curtis; Mario F Feldman
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

2.  The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs.

Authors:  Amir E Zeituni; William McCaig; Elizabeth Scisci; David G Thanassi; Christopher W Cutler
Journal:  J Bacteriol       Date:  2010-06-18       Impact factor: 3.490

3.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Inactivation of vimF, a putative glycosyltransferase gene downstream of vimE, alters glycosylation and activation of the gingipains in Porphyromonas gingivalis W83.

Authors:  Elaine Vanterpool; Francis Roy; Hansel M Fletcher
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Does the importance of the C-terminal residues in the maturation of RgpB from Porphyromonas gingivalis reveal a novel mechanism for protein export in a subgroup of Gram-Negative bacteria?

Authors:  Ky-Anh Nguyen; James Travis; Jan Potempa
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

6.  C-terminal domain residues important for secretion and attachment of RgpB in Porphyromonas gingivalis.

Authors:  Nada Slakeski; Christine A Seers; Kaiting Ng; Caroline Moore; Steven M Cleal; Paul D Veith; Alvin W Lo; Eric C Reynolds
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

7.  PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis.

Authors:  Michelle D Glew; Paul D Veith; Benjamin Peng; Yu-Yen Chen; Dhana G Gorasia; Qiaohui Yang; Nada Slakeski; Dina Chen; Caroline Moore; Simon Crawford; Eric C Reynolds
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

8.  Tetratricopeptide repeat protein-associated proteins contribute to the virulence of Porphyromonas gingivalis.

Authors:  Yoshio Kondo; Naoya Ohara; Keiko Sato; Mamiko Yoshimura; Hideharu Yukitake; Mariko Naito; Taku Fujiwara; Koji Nakayama
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

9.  Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis.

Authors:  Joseph Aduse-Opoku; Jennifer M Slaney; Ahmed Hashim; Alexandra Gallagher; Robert P Gallagher; Minnie Rangarajan; Khalil Boutaga; Marja L Laine; Arie J Van Winkelhoff; Michael A Curtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

10.  Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells.

Authors:  Margaret A Scragg; Asil Alsam; Minnie Rangarajan; Jennifer M Slaney; Philip Shepherd; David M Williams; Michael A Curtis
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.